Novartis acquires Amblyotech, pursuing novel digital therapy for child...
Amblyotech. Technology has potential to reimagine treatment for amblyopia (“lazy eye”), a leading cause of vision loss in children and...
Read Amblyotech.com news digest here: view the latest Amblyotech articles and content updates right away or get to their most visited pages. Amblyotech.com is not yet rated by Alexa and its traffic estimate is unavailable. We haven’t detected security issues or inappropriate content on Amblyotech.com and thus you can safely use it. Amblyotech.com is hosted with CloudFlare, Inc. (United States) and its basic language is English.
Content verdict: Safe
Website availability: Live
Language: English
Last check:
-
N/A
Visitors daily -
N/A
Pageviews daily -
N/A
Google PR -
N/A
Alexa rank
Best pages on Amblyotech.com
-
Technology has potential to reimagine treatment for amblyopia (“lazy eye”), a leading cause of vision loss in children and young adults1Acquisition expands the Novartis refractive disorder pipeline in...
-
Scientific Advisory Board - Amblyotech
Professor Robert F. Hess Professor Hess is the Director of Research at the Department of Ophthalmology, McGill University, Canada, and Director of its Vision Research Unit. He is also an associate...
-
Apr 20, 2020 Technology has potential to reimagine treatment for amblyopia (“lazy eye”), a leading cause of vision loss in children and young adults 1 Acquisition expands the Novartis refractive diso...
Domain history
| Web host: | CloudFlare, Inc. |
| Registrar: | MarkMonitor Inc. |
| Registrant: | Amblyotech Inc. |
| Updated: | November 05, 2023 |
| Expires: | August 30, 2024 |
| Created: | August 30, 2013 |
Whois record
Safety scores
Trustworthiness
N/AChild safety
N/A
